DATASEA INC (DTSS)

US2381163052 - Common Stock

2.15  +0.03 (+1.42%)

Premarket: 2.2 +0.05 (+2.33%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DTSS. DTSS was compared to 284 industry peers in the Software industry. DTSS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. DTSS does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

DTSS had negative earnings in the past year.
In the past year DTSS has reported a negative cash flow from operations.
In the past 5 years DTSS always reported negative net income.
In the past 5 years DTSS always reported negative operating cash flow.

1.2 Ratios

DTSS has a worse Return On Assets (-167.37%) than 95.70% of its industry peers.
DTSS has a worse Return On Equity (-324.63%) than 85.30% of its industry peers.
Industry RankSector Rank
ROA -167.37%
ROE -324.63%
ROIC N/A
ROA(3y)-287.82%
ROA(5y)-204.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

DTSS has a Gross Margin of 1.56%. This is amonst the worse of the industry: DTSS underperforms 89.61% of its industry peers.
In the last couple of years the Gross Margin of DTSS has declined.
The Profit Margin and Operating Margin are not available for DTSS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.73%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

DTSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DTSS has been increased compared to 1 year ago.
DTSS has more shares outstanding than it did 5 years ago.
DTSS has a better debt/assets ratio than last year.

2.2 Solvency

DTSS has an Altman-Z score of -5.11. This is a bad value and indicates that DTSS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DTSS (-5.11) is worse than 86.38% of its industry peers.
There is no outstanding debt for DTSS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.11
ROIC/WACCN/A
WACC9.23%

2.3 Liquidity

DTSS has a Current Ratio of 1.91. This is a normal value and indicates that DTSS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.91, DTSS is in line with its industry, outperforming 57.71% of the companies in the same industry.
DTSS has a Quick Ratio of 1.86. This is a normal value and indicates that DTSS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.86, DTSS is in line with its industry, outperforming 55.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.86

3

3. Growth

3.1 Past

DTSS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.02%.
Looking at the last year, DTSS shows a very strong growth in Revenue. The Revenue has grown by 254.63%.
The Revenue has been growing by 415.52% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)5.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4755.1%
Revenue 1Y (TTM)254.63%
Revenue growth 3Y415.52%
Revenue growth 5YN/A
Sales Q2Q%206.37%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

DTSS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DTSS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DATASEA INC

NASDAQ:DTSS (1/14/2025, 8:00:01 PM)

Premarket: 2.2 +0.05 (+2.33%)

2.15

+0.03 (+1.42%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14 2022-11-14/bmo
Earnings (Next)N/A N/A
Inst Owners0.2%
Inst Owner Change0%
Ins Owners43.87%
Ins Owner Change0%
Market Cap15.24M
Analysts82.86
Price TargetN/A
Short Float %0.63%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B 3.72
P/tB 4.25
EV/EBITDA N/A
EPS(TTM)-4.46
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS5.38
BVpS0.58
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -167.37%
ROE -324.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.56%
FCFM N/A
ROA(3y)-287.82%
ROA(5y)-204.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.73%
GM growth 5YN/A
F-Score4
Asset Turnover4.8
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 48.65%
Cap/Sales 0.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 1.86
Altman-Z -5.11
F-Score4
WACC9.23%
ROIC/WACCN/A
Cap/Depr(3y)78.93%
Cap/Depr(5y)119.93%
Cap/Sales(3y)2.78%
Cap/Sales(5y)25.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4755.1%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)254.63%
Revenue growth 3Y415.52%
Revenue growth 5YN/A
Sales Q2Q%206.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-60.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y89.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.38%
OCF growth 3YN/A
OCF growth 5YN/A